MET and cancer: Thus, we selected cancer cell lines of different origin (NCI-H226, NCI-H441 non-small cell lung carcinoma, and Caki-I clear cell renal carcinoma) characterized by MET overexpression in the absence of high MET gene amplification (Suppl.